Display Settings:

Format

Send to:

Choose Destination
Trends Mol Med. 2007 Dec;13(12):527-34. Epub 2007 Nov 5.

The HER family and cancer: emerging molecular mechanisms and therapeutic targets.

Author information

  • 1University of California, San Francisco, San Francisco, CA 94143, USA.

Abstract

The human epidermal growth factor receptor (HER) family of transmembrane tyrosine kinases regulates diverse cellular functions in response to extracellular ligands. The deregulation of HER signaling through gene amplification or mutation is seen in many human tumors and an abundance of experimental evidence supports the etiological role of these events in cancer pathogenesis. In addition, the fact that they are feasible targets for both antibody and small-molecule therapeutics has made them highly pursued targets for the development of rationally designed anticancer drugs. Several HER-targeting agents have entered clinical practice and this has led to novel discoveries regarding the mechanisms of resistance, which has defined a new generation of challenges for targeted cancer therapies. Here, we review recent advances in our understanding of HER signaling and targeting in cancer.

PMID:
17981505
[PubMed - indexed for MEDLINE]
PMCID:
PMC3035105
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk